Additional Prezista tablet strength available

Tibotec has launched Prezista 600mg (darunavir tablet) in addition to the 300mg dosage strength already available. Prezista, a protease inhibitor, is indicated for treating HIV infection in antiretroviral treatment-experienced adults when co-administered with ritonavir and other antiretroviral agents.

For more information call (877) REACH-TT or visit www.prezista.com.